3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic-acid and Breast-Neoplasms

Understanding vascular growth and maturation in developing tumors has important implications for tumor progression, spread, and ultimately host survival. Modulating the signaling of endothelial G protein-coupled receptors (GPCRs) in blood and lymphatic vessels can enhance or limit tumor progression. Sphingosine 1-phosphate receptor 1 (S1PR1) is a GPCR for circulating lysophospholipid S1P that is highly expressed in blood and lymphatic vessels. Using the S1PR1- enhanced green fluorescent protein (eGFP) mouse model in combination with intravital imaging and pharmacologic modulation of S1PR1 signaling, we show that boundary conditions of high and low S1PR1 signaling retard tumor progression by enhancing or destabilizing neovasculature integrity, respectively. In contrast, midrange S1PR1 signaling, achieved by receptor antagonist titration, promotes abundant growth of small, organized vessels and thereby enhances tumor progression. Furthermore, in vivo S1PR1 antagonism supports lung colonization by circulating tumor cells. Regulation of endothelial S1PR1 dynamically controls vascular integrity and maturation and thus modulates angiogenesis, tumor growth, and hematogenous metastasis.

Topics: Anilides; Animals; Breast Neoplasms; Capillary Permeability; Endothelial Cells; Female; Green Fluorescent Proteins; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Organophosphonates; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine-1-Phosphate Receptors; Time Factors; Tumor Burden